Western blot analysis of important signaling molecules involved in prostate cancer demonstrated that the AR protein expression was significantly reduced by arctigenin treatment compared to HF control, along with a significantly increased protein expression of Nkx3.1 (Fig. 4A,B). The gene discussed is AR; the disease is prostate cancer.